These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 15224032)

  • 1. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
    Casali C; Stefani A; Natali P; Rossi G; Morandi U
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
    Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
    Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
    Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
    Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
    Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
    J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
    Varlotto JM; Flickinger JC; Recht A; Nikolov MC; DeCamp MM
    Cancer; 2008 Apr; 112(7):1547-54. PubMed ID: 18260087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.